The present invention relates generally to medical devices and methods and more particularly to apparatus and methods for providing embolic protection to a patient's aortic arch vessels during cardiac surgery and interventional cardiology procedures.
Cerebral embolism is a known complication of cardiac surgery, cardiopulmonary bypass and catheter-based interventional cardiology and electrophysiology procedures. Embolic particles, which may include thrombus, atheroma, and lipids, may become dislodged by surgical or catheter manipulations and enter the bloodstream, embolizing in the brain or other vital organs downstream. Cerebral embolism can lead to neuropsychological deficits, stroke and even death.
Prevention of embolism would benefit patients and improve the outcome of many surgical procedures. Many current devices for preventing cerebral embolism may be less than ideal in various respects. For example, such current devices may involve multiple components and multiple steps, making the use of such devices cumbersome and even injury-prone for the patient. Also, when used with other catheter-based interventional tools, the patient's vasculature may need to be accessed at multiple points and through multiple paths. For example, a current embolic protection device may be advanced into the aortic arch through the descending aorta while other catheter-based interventional tools may then need to be advanced into or into proximity with the heart through other blood vessels including the vena cava, the right common carotid artery, and the left common carotid artery.
U.S. Patent Publ. 2013/0178891, commonly assigned herewith, describes an embolic protection device having embolic protection elements that are combined with an access sheath suitable advancing a diagnostic catheter. The embolic protection elements include an embolic filter slidably mounted on a distal portion of the sheath, a proximal stop for limiting the proximal movement of the embolic filter, and a distal stop for limiting the distal movement of the embolic filter. The filter comprises a porous mesh material defining a collection chamber for captured emboli and has a collapsed and a deployed configuration. The filter may be collapsed by an access sheath used with the catheter. An access sheath may comprise a tubular main body and an embolic filter mounted on the distal portion of the tubular main body. The embolic filter may revert into the central lumen of the sheath or may be constrained on the exterior of the sheath with a larger diameter outer tube.
While very effective for protecting the aortic branch vessels from emboli, the illustrated access sheath allows only a single catheter at a time to pass through the filter. Moreover, the sheath dimensions can limit the size of catheter which can be introduced which is a particular concern if a valvuloplasty catheter or prosthetic aortic or other valve is to be delivered over the aortic arch to the heart. Therefore, improved devices, systems, and methods for preventing embolism during cardiac procedures performed over the aortic arch that overcome at least some of the aforementioned short-comings are desired.
U.S. Patent Publ. 2013/0178891 has been described above. Other devices for capturing or blocking emboli to prevent cerebral embolism are described in the following patent application and patent publications: U.S. Pub. No. 2010/0312268 to Belson, entitled “Embolic Protection Device”; U.S. Pub. No. 2004/0215167 to Belson, entitled “Embolic Protection Device”; U.S. Pub. No. 2003/0100940 to Yodfat, entitled “Implantable Intraluminal Protector Device and Method of Using Same for Stabilizing Atheromoas”; PCT Pub. No. WO/2004/019817 to Belson, entitled “Embolic Protection Device”; U.S. Pat. No. 6,537,297 to Tsugita et al., entitled “Methods of Protecting a Patient from Embolization During Surgery”; U.S. Pat. No. 6,499,487 to McKenzie et al., entitled “Implantable Cerebral Protection Device and Method of Use”; U.S. Pat. No. 6,371,935 to Macoviak et al., entitled “Aortic Catheter with Flow Divider and Methods for Preventing Cerebral Embolization”; U.S. Pat. No. 6,361,545 to Macoviak et al., entitled “Perfusion Filter Catheter”; U.S. Pat. No. 6,254,563 to Macoviak et al., entitled “Perfusion Shunt Apparatus and Method”; U.S. Pat. No. 6,139,517 to Macoviak et al., entitled “Perfusion Shunt Apparatus and Method”; and U.S. Pat. No. 5,769,819 to Barbut et al., entitled “Cannula with Associated Filter.”
The present invention provides methods, systems, and devices for collecting emboli and in particular for preventing the release of emboli into the cerebral vasculature during the performance of interventional procedures in a patient's aorta, including aortic valve replacement, aortic valve valvuloplasty, and the like, where there is a risk of emboli being released into the aortic side vessels, including the brachiocephalic artery, the left carotid artery, and the left subclavian artery. The present invention provides an embolic protection device and system which can be placed through the descending aorta and over the aortic arch to inhibit emboli release into the aortic side branch vessels while allowing simultaneous access to the aortic valve by at least two interventional and/or diagnostic catheters being introduced from the descending aorta, typically by conventional femoral artery access.
The embolic protection device will include both an embolic filter and an inner sheath connected to the embolic filter. The inner sheath is attached to or on a downstream portion of the embolic filter, where downstream refers to the direction towards the descending aorta and away from the heart and aortic arch. The inner sheath has a lumen and will provide a first access route to an interior of the embolic filter for introducing one diagnostic or interventional catheter at a time. At least one additional port will be formed in the embolic filter for introducing at least one additional catheter so that the additional or second catheter can be present within the interior of the embolic filter simultaneously with the initial or first catheter introduced through the sheath. The additional port will typically have an expandable diameter so it will remain generally closed when no catheter is present but will be able to open and to conform to catheters of different diameters as they are introduced therethrough into the interior of the embolic filter and typically onward to the aortic valve for performing an aortic intervention.
In a first specific aspect of the present invention an embolic protection device comprises an inner sheath having a lumen with a distal opening and an embolic filter. The embolic filter comprises a porous mesh material having a cylindrical outer wall which defines an interior which includes a collections chamber for capturing emboli. The filter has an open upstream end and a closed downstream end, where blood and emboli my enter through the open upstream end and deposit within the collection chamber which is at least partially defined by the closed downstream end. The filter will further have both a radially collapsed delivery configuration and a radially expanded configuration, and the outer wall will typically be configured to contact a blood vessel wall to direct blood flow through the upstream end and emboli into the collection chamber. The embolic filter will have at least a first port comprising an expandable opening configured to conform to an outer wall of a first catheter passing there through and a second port which is attached to the inner sheath to allow a second catheter to be advanced through the lumen of the inner sheath so that it can enter the interior of the embolic filter.
In specific embodiments of the embolic protection device of the present invention, at least one of the first port and the second port is formed in the closed downstream end of the embolic filter. Often, both the first and second ports will be formed in the closed downstream end, but in other embodiments at least one of the ports may be formed through the cylindrical outer wall of the porous mesh material, for example where the inner sheath may pass through a port or opening though the cylindrical outer wall at a location in an upstream direction from the closed downstream end of the filter.
In still other embodiments of the embolic protection device, the embolic filter further includes at least a first conical inner portion which defines the collection chamber between an inner surface of the outer cylindrical wall and an outer surface of the conical inner portion. In such embodiments, an apical end of the conical inner portion will be oriented towards the open upstream end of the embolic filter. Typically, the first port having an expandable opening will be formed at or in the apical end of the conical portion, in such embodiments, the conical portion will have a wide opening at its downstream end to facilitate entry of a diagnostic or interventional catheter through the expandable port. The expandable port may comprise a simple slit or duck-bill-like opening, or optionally may further comprise a resilient seal positioned within or over the port for conforming to a catheter as it passes through the port.
In still further embodiments, the embolic protection device may include a second conical inner portion which, together with the first conical inner portion, will define the collection chamber between the inner surface of the cylindrical outer wall and the outer surfaces of both the first and second conical inner portions. In such instances, the apical end of the second conical inner portion will be oriented towards the upstream end of the embolic filter, and typically the inner sheath is attached to the apical end of the second conical inner portion, more typically being attached so that an upstream end of the inner sheath will be positioned beyond the apical end of the second conical structure in the upstream direction.
In still other embodiments, a distal portion of the inner sheath may pass through the second port of the embolic filter and extend in an upstream direction some distance within the interior of cylindrical wall. In some cases, the inner sheath may be attached to the cylindrical wall or, in other cases, to a side wall of the first conical inner portion. In still other embodiments, the inner sheath may pass through a wall of the first conical inner portion so that the sheath enters the embolic filter through the open downstream end of the conical inner portion and then passes into the interior of the filter portion through the wall of the conical inner portion. A variety of other ways for attaching the inner sheath to the embolic filter described in more detail below.
The porous mesh material will typically be formed from an elastic or super elastic metal, such as nickel-titanium alloy, which can be preformed into its radially expanded configuration and then constrained into its radially collapsed delivery configuration, either by an external outer delivery sheath or by an internal stylet used to elongate the embolic filter. Other available materials for the porous mesh included knitted fabrics, woven fabrics, woven fibers, non-woven fibers, filaments, and wires having a pore size chosen to prevent emboli larger than a predetermined size from passing through the mesh. Other materials include other metals, polymer materials, plastically deformable materials, and the like. In the case of malleable and plastically deformable materials, further structure may be provided to radially expand and radially collapse the embolic filter before delivery and deployment. Typical pore sizes for the mesh materials are in the range from about 0.1 mm to about 1 mm, and the porous mesh material will typically be coated with an anti-thrombogenic coating. Radiopaque markers will be typically provided on the embolic filter and/or the inner sheath.
In a second aspect of the present invention, a method for advancing a catheter over an aortic arch having aortic side vessels comprises providing an embolic protection device including a cylindrical outer sleeve formed at least partly from a porous mesh and having an interior which defines a collection chamber for captured emboli. The embolic protection filter will have an open upstream end, a closed downstream end, a radially collapsed delivery configuration, and a radially expanded configuration for deployment within the aortic arch. The cylindrical outer sleeve is radially expanded so that the porous mesh covers the aortic side vessels and the upstream faces the heart to direct blood flow through the upstream end of the filter and emboli into the collection chamber. As a result, blood flowing into the aortic side vessels will pass through the porous mesh which will separate the emboli. After the filter is in position, a first catheter may be advanced from an arterial lumen downstream of the closed downstream end of the embolic protection filter through a first port therein. A second catheter may be advanced from the same or a different arterial lumen downstream of the closed downstream end of the embolic protection filter through a second port. In this way, at least two catheters may be simultaneously introduced into the interior of the filter and optionally beyond to the aortic valve in order to perform the desired aortic valve interventions. For example, a small catheter for delivering contrast media may be introduced through one of the ports while a second interventional catheter may be delivered through the other port. The contrast delivery catheter may be positioned within the filter to release contrast media, while the interventional catheter may be advanced out through the open upstream end of the filter in order to perform the desired intervention on the aortic valve.
In a first specific embodiment of the methods of the present invention, the embolic protection filter may further include a first conical inner structure formed through the cylindrical outer sleeve and having an apical end directed into the blood flow from the heart. The first port may be disposed at or near the apical end of the first conical inner structure where the availability of the enlarged downstream end of the conical port is particularly advantageous for receiving larger, interventional catheters therethrough.
In still other embodiments, a second inner sheath may be attached to the second port so that the second catheter may be advanced through a lumen of the inner sheath before passing through the second port. The inclusion of the inner sheath provides a number of advantages. As a first advantage, the inner sheath may be used to advance and position the embolic protection filter within the aortic arch. For example, the inner sheath may be used to advance the embolic protection filter through an outer delivery sheath that constrains the embolic protection filter and its radially collapsed configuration while it is being delivered. The embolic protection filter will typically be self-expanding, as described above, allowing it to radially expand and assume its deployed configuration as it is advanced beyond a distal end of the delivery sheath. Alternatively, a stylet may be positioned within the inner sheath and extend through the embolic protection filter to selectively elongate and radially collapse the embolic protection filter while it is being delivered. When using the stylet, the embolic protection filter may be radially expanded by proximally retracting the stylet relative to the filter to release the filter from radial constraint.
The embolic protection device will usually be self-supporting in the deployed condition. In other embodiments, however, the filter can include one or more “stent-like” support structures that may comprise, for example, a framework having one or more longitudinal struts or hoops that form a an outer surrounding and/or inner supporting lattice structure that assists in the expansion and wall apposition of the device. The hoops and struts may be made of a resilient metal and/or polymer material to make a self-expanding framework or a malleable or plastically deformable material to make a framework that can be expanded with an inflatable balloon or other expansion mechanism. Alternatively, the framework can be made of a shape-memory material that can be used to deploy and/or retract the embolic protection device.
The length of embolic protection device of the present invention should be sufficient to cover the aortic side vessels and to extend sufficiently into the ascending and descending regions of the aorta on both sides of the side vessels to assure that no emboli can bypass the filter. Beyond that requirement, the length of the device is not critical and may be constructed with the filter mesh structure and optionally the “stent-like” support structure made either longer or shorter without adversely affecting the performance of the product. In other alternate construction, the “stent” support structure need not be cylindrical can for example be made slightly conical with the wider end of the cone oriented toward the upstream direction.
The embolic protection device of the present invention may be retracted and withdrawn together with or after the catheters used to perform a diagnostic or interventional procedure at the end of the procedure. Optionally, the embolic protection device may include features to assist in retracting the device for retrieval from the vessel. In one embodiment, a conical guiding structure may be slidably attached to the catheter at the proximal end of the device, the purpose of which is to assist the embolic protection device in collapsing when a retrieval sheath is advanced along the conical guiding structure. In another embodiment, portions of the embolic protection device may be constructed with retraction members or retrieval wires that are configured like purse strings or lassos around the circumference of the device. A pull loop or other graspable structure near the downstream end of the embolic protection device may be connected to the retraction members by one or more connecting members.
In still further embodiments, the filter may contain one or more support structures or wires that provide longitudinal stiffness to the device to prevent compression or movement of the filter during the procedure. Such wires or structures may extend the full length of the device or only for a portion of its length and such wires or structures shall be either fixedly or slidably attached to the access sheath.
Referring to
The cylindrical wall 12 will typically be a single layer or multiple layer porous mesh, usually formed from elastic wires, filaments, tapes, and most usually being formed from super elastic wires woven into a porous structure having a pore size typically in the range from 0.1 mm to 1 mm, usually from 0.1 mm to 0.2 mm.
In preferred constructions of the embolic filter 11 and cylindrical outer wall 12, the porous mesh will be elastic and pre-formed in a radially expanded configuration (so that it can be delivered in a radially constrained configuration and released from constraint to self-expand at the location of implantation in the target blood vessel) which is somewhat larger than a target blood vessel, typically larger than a target aorta, thus usually having a diameter in the range from 15 mm to 60 mm when unconstrained, more usually having a diameter in the range from 25 mm to 45 mm when unconstrained.
The embolic filter component 11 will also have a radially collapsed delivery configuration with a reduced diameter or profile kind of typically in the range from 2 mm to 6 mm, preferably in the range from 2 mm to 4 mm. The porous mesh construction is particularly suitable for axially elongating and radially collapsing the embolic filter component, and thus a preferred construction will be a woven mesh which is otherwise minimally supported or unsupported by any other structure. In other embodiments, however, it would be possible to provide either additional or internal support structures, such as stents, scaffolds, struts, grafts, coatings, circumscribing rings, or the like, depending on the desired specific mechanical characteristics. For the most part, however, such additional structural support will be unnecessary as the woven porous mesh structure when radially expanded will have sufficient hoop strength and column strength to both deploy and be maintained within the aorta arch, as described in more detail below.
The embolic filter component 11 of the embolic protection device 10 will also include at least a first port and a second port to allow catheter access from the outside of the embolic filter component to the inside of the embolic filter component. Often, the first port and the second port will be located on or near the closed distal end 20 of the embolic filter component. In other instances, either the first port, the second port or both the first and second ports, will be formed through the side wall 12 of the embolic filter component 10. Various specific implementations are illustrated in
In
In
As shown in
Referring now to
Referring now to
Referring now to
In a still further embodiment, as illustrated in
In another embodiment, as illustrated in
In a still further embodiment of the inner sheath attachment detail, as shown in
As a final exemplary embodiment of the inner sheath attachment detail as illustrated in
Referring now to
An alternative structure for radially collapsing the embolic filter component 11 is shown in
Referring now to
As shown in
As shown in
As shown in
The methods and apparatus of the present invention are not limited to any particular interventional or diagnostic catheters or the performance of any particular interventional or diagnostic procedures. Instead, the access ports 22 and 24 can provide for introduction of a wide variety of catheters and tools for performing a number of desired interventions on the aortic valve or anywhere in ascending aorta therein. Further alternative embodiments may include more than two access ports, at least one of which will be expandable as with port 22 and at least one of which will be fixedly attached to an access sheath as with port 24. Additional expandable ports may also include additional inner conical portions.
This application is a continuation of U.S. patent application Ser. No. 14/537,814, filed Nov. 10, 2014, now U.S. Pat. No. 9,877,821, which claims the benefit of U.S. Provisional Application No. 62/050,156, filed Sep. 14, 2014, the full disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4723549 | Wholey et al. | Feb 1988 | A |
4790809 | Kuntz | Dec 1988 | A |
5108419 | Reger et al. | Apr 1992 | A |
5197485 | Grooters | Mar 1993 | A |
5769816 | Barbut et al. | Jun 1998 | A |
5769819 | Schwab et al. | Jun 1998 | A |
5797880 | Erskine | Aug 1998 | A |
5800525 | Bachinski et al. | Sep 1998 | A |
5807327 | Green et al. | Sep 1998 | A |
6013051 | Nelson | Jan 2000 | A |
6083239 | Addis | Jul 2000 | A |
6117154 | Barbut et al. | Sep 2000 | A |
6120534 | Ruiz | Sep 2000 | A |
6139517 | Macoviak et al. | Oct 2000 | A |
6152144 | Lesh et al. | Nov 2000 | A |
6245012 | Kleshinski | Jun 2001 | B1 |
6254563 | Macoviak et al. | Jul 2001 | B1 |
6254633 | Pinchuk et al. | Jul 2001 | B1 |
6258120 | McKenzie et al. | Jul 2001 | B1 |
6348063 | Yassour et al. | Feb 2002 | B1 |
6355051 | Sisskind et al. | Mar 2002 | B1 |
6361545 | Macoviak et al. | Mar 2002 | B1 |
6371935 | Macoviak et al. | Apr 2002 | B1 |
6461370 | Gray et al. | Oct 2002 | B1 |
6499487 | McKenzie et al. | Dec 2002 | B1 |
6537297 | Tsugita et al. | Mar 2003 | B2 |
6547760 | Samson et al. | Apr 2003 | B1 |
6682543 | Barbut et al. | Jan 2004 | B2 |
6692513 | Streeter et al. | Feb 2004 | B2 |
6695864 | Macoviak et al. | Feb 2004 | B2 |
6709415 | Navia et al. | Mar 2004 | B2 |
6712834 | Yassour et al. | Mar 2004 | B2 |
6746469 | Mouw | Jun 2004 | B2 |
6808520 | Fourkas et al. | Oct 2004 | B1 |
7044958 | Douk et al. | May 2006 | B2 |
7232453 | Shimon | Jun 2007 | B2 |
7235060 | Kraus | Jun 2007 | B2 |
7537600 | Eskuri et al. | May 2009 | B2 |
7758606 | Streeter et al. | Jul 2010 | B2 |
7766932 | Melzer et al. | Aug 2010 | B2 |
8052717 | Mujkanovic et al. | Nov 2011 | B2 |
8114114 | Belson | Feb 2012 | B2 |
8123779 | Demond et al. | Feb 2012 | B2 |
8298258 | Anderson et al. | Oct 2012 | B2 |
8308754 | Belson | Nov 2012 | B2 |
8337519 | Wasicek et al. | Dec 2012 | B2 |
8382788 | Galdonik et al. | Feb 2013 | B2 |
8414482 | Belson | Apr 2013 | B2 |
8420902 | Gilsinger et al. | Apr 2013 | B2 |
8430904 | Belson | Apr 2013 | B2 |
8679149 | Belson | Mar 2014 | B2 |
8728114 | Belson | May 2014 | B2 |
8740930 | Goodwin et al. | Jun 2014 | B2 |
8968354 | Wang et al. | Mar 2015 | B2 |
9107734 | Belson | Aug 2015 | B2 |
9144485 | Bergheim et al. | Sep 2015 | B2 |
9492265 | Russell et al. | Nov 2016 | B2 |
9744023 | Wang et al. | Aug 2017 | B2 |
9827085 | Russell et al. | Nov 2017 | B2 |
9877821 | Russell et al. | Jan 2018 | B2 |
20010044632 | Daniel et al. | Nov 2001 | A1 |
20020004667 | Adams et al. | Jan 2002 | A1 |
20020058964 | Addis | May 2002 | A1 |
20020128680 | Pavlovic | Sep 2002 | A1 |
20030040736 | Stevens et al. | Feb 2003 | A1 |
20030100940 | Yodfat | May 2003 | A1 |
20030171803 | Shimon | Sep 2003 | A1 |
20040034380 | Woolfson et al. | Feb 2004 | A1 |
20040073253 | Morrill et al. | Apr 2004 | A1 |
20040138692 | Phung et al. | Jul 2004 | A1 |
20040215167 | Belson | Oct 2004 | A1 |
20040225354 | Allen et al. | Nov 2004 | A1 |
20050010246 | Streeter et al. | Jan 2005 | A1 |
20050137696 | Salahieh et al. | Jun 2005 | A1 |
20050283186 | Berrada et al. | Dec 2005 | A1 |
20060287668 | Fawzi et al. | Dec 2006 | A1 |
20060293706 | Shimon | Dec 2006 | A1 |
20070027534 | Bergheim et al. | Feb 2007 | A1 |
20070060944 | Boldenow et al. | Mar 2007 | A1 |
20070073246 | Simon | Mar 2007 | A1 |
20070073332 | Miller et al. | Mar 2007 | A1 |
20080027481 | Gilson et al. | Jan 2008 | A1 |
20090149881 | Vale et al. | Jun 2009 | A1 |
20100010535 | Mujkanovic et al. | Jan 2010 | A1 |
20100274277 | Eaton | Oct 2010 | A1 |
20100312268 | Belson | Dec 2010 | A1 |
20120016408 | Barbut et al. | Jan 2012 | A1 |
20120109182 | Belson | May 2012 | A1 |
20120109183 | Belson | May 2012 | A1 |
20120271340 | Castellano et al. | Oct 2012 | A1 |
20130035716 | Belson | Feb 2013 | A1 |
20130035717 | Belson | Feb 2013 | A1 |
20130096606 | Bruchman et al. | Apr 2013 | A1 |
20130178891 | Russell et al. | Jul 2013 | A1 |
20130238011 | Belson | Sep 2013 | A1 |
20130245669 | Basu et al. | Sep 2013 | A1 |
20130267993 | Carpenter et al. | Oct 2013 | A1 |
20140000091 | Angel et al. | Jan 2014 | A1 |
20140058372 | Belson | Feb 2014 | A1 |
20140155929 | Belson | Jun 2014 | A1 |
20140214069 | Franklin et al. | Jul 2014 | A1 |
20140249568 | Adams et al. | Sep 2014 | A1 |
20150066075 | Russell et al. | Mar 2015 | A1 |
20150320540 | Belson | Nov 2015 | A1 |
20150366650 | Zi et al. | Dec 2015 | A1 |
20160317277 | Carpenter et al. | Nov 2016 | A1 |
20180206970 | Eggert et al. | Jul 2018 | A1 |
20190015152 | Howard et al. | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
2609800 | Jan 2007 | CA |
101351242 | Jan 2009 | CN |
102256566 | Nov 2011 | CN |
102973332 | Mar 2013 | CN |
H09276414 | Oct 1997 | JP |
2007527264 | Sep 2007 | JP |
WO-03094791 | Nov 2003 | WO |
WO-2004019817 | Mar 2004 | WO |
WO-2004021922 | Mar 2004 | WO |
WO-2006138391 | Dec 2006 | WO |
WO-2009038799 | Mar 2009 | WO |
WO-2013103979 | Jul 2013 | WO |
WO-2016040923 | Mar 2016 | WO |
WO-2016040923 | Aug 2016 | WO |
WO2017116828 | Jul 2017 | WO |
Entry |
---|
US 6,348,062 B1, 02/2002, Hopkins et al. (withdrawn) |
International search report and written opinion dated May 5, 2017 for PCT Application No. PCT/US2016/067686. |
“IPRP for PCT/US2016/067686 Jul. 3, 2018”. |
Notice of allowance dated Jul. 14, 2016 for U.S. Appl. No. 13/735,864. |
Notice of allowance dated Sep. 1, 2017 for U.S. Appl. No. 15/335,322. |
Office action dated Feb. 9, 2017 for U.S. Appl. No. 15/335,322. |
European search report and search opinion dated Apr. 17, 2015 for EP Application No. 13733627.7. |
International search report and written opinion dated Apr. 9, 2008 for PCT/US2007/024558. |
International search report and written opinion dated Apr. 22, 2013 for PCT Application No. US2013/20563. |
“International search report and written opinion dated Dec. 14, 2015 for PCT/US2015/049908.” |
International search report dated Jan. 15, 2004 for PCT/US2003/026938. |
International search report with written opinion dated Dec. 14, 2015 for PCT/US2015/049908. |
Notice of allowance dated Feb. 26, 2013 for U.S. Appl. No. 13/648,986. |
Notice of allowance dated Mar. 1, 2013 for U.S. Appl. No. 13/343,538. |
Notice of allowance dated Apr. 15, 2015 for U.S. Appl. No. 12/532,630. |
Notice of allowance dated Aug. 10, 2012 for U.S. Appl. No. 13/347,046. |
Notice of Allowance dated Nov. 1, 2013 for U.S. Appl. No. 13/648,992. |
Notice of Allowance dated Nov. 18, 2013 for U.S. Appl. No. 13/866,887. |
Notice of Allowance dated Nov. 23, 2011 for U.S. Appl. No. 10/493,854. |
Office action dated Jan. 17, 2012 for U.S. Appl. No. 12/532,630. |
Office action dated Jan. 17, 2013 for U.S. Appl. No. 13/648,992. |
Office action dated Jan. 24, 2014 for U.S. Appl. No. 13/735,864. |
Office action dated Feb. 11, 2009 for U.S. Appl. No. 10/493,854. |
Office action dated Feb. 26, 2008 for U.S. Appl. No. 10/493,854. |
Office action dated Feb. 26, 2014 for U.S. Appl. No. 12/532,630. |
Office action dated Mar. 13, 2013 for U.S. Appl. No. 12/532,630. |
Office action dated Apr. 10, 2012 for U.S. Appl. No. 13/343,538. |
Office action dated Apr. 10, 2013 for U.S. Appl. No. 12/532,630. |
Office action dated Jun. 10, 2013 for U.S. Appl. No. 12/532,630. |
Office action dated Jul. 12, 2011 for U.S. Appl. No. 10/493,854. |
Office action dated Jul. 17, 2013 for U.S. Appl. No. 13/735,864. |
Office action dated Jul. 23, 2013 for U.S. Appl. No. 13/648,992. |
Office action dated Jul. 23, 2013 for U.S. Appl. No. 13/866,887. |
Office action dated Aug. 20, 2010 for U.S. Appl. No. 10/493,854. |
Office action dated Aug. 25, 2015 for U.S. Appl. No. 14/175,042. |
Office action dated Sep. 14, 2011 for U.S. Appl. No. 10/493,854. |
Office action dated Nov. 6, 2012 for U.S. Appl. No. 12/532,630. |
Office action dated Nov. 6, 2015 for U.S. Appl. No. 14/801,850. |
Office action dated Nov. 19, 2013 for U.S Appl. No. 12/532,630. |
Office action dated Dec. 11, 2012 for U.S. Appl. No. 13/343,538. |
Notice of allowance dated Oct. 25, 2017 for U.S. Appl. No. 14/537,814. |
Office action dated Mar. 7, 2017 for U.S. Appl. No. 14/537,814. |
EP15840142.2 Extended European Search Report dated Mar. 15, 2018. |
Number | Date | Country | |
---|---|---|---|
20180110607 A1 | Apr 2018 | US |
Number | Date | Country | |
---|---|---|---|
62050156 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14537814 | Nov 2014 | US |
Child | 15848762 | US |